SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Söderholm Jonas) "

Sökning: WFRF:(Söderholm Jonas)

  • Resultat 1-10 av 64
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Kalla, Rahul, et al. (författare)
  • EPIGENETIC ALTERATIONS IN IBD : DEFINING GEOGRAPHICAL, GENETIC, AND IMMUNEIN-FLAMMATORY INFLUENCES ON THE CIRCULATING METHYLOME
  • 2021
  • Ingår i: Gut. - : BMJ Publishing Group Ltd. - 0017-5749 .- 1468-3288. ; 70:Suppl. 4, s. A5-A5
  • Tidskriftsartikel (övrigt vetenskapligt/konstnärligt)abstract
    • Introduction: DNA methylation may provide critical insights into gene-environment interactions in inflammatory bowel disease (IBD).Methods: Using the multi-centre IBD Character inception cohort (295 controls, 154 CD, 161 UC, 28 IBD-U), epigenome-wide methylation was profiled using Illumina HumanMethylation450 platform. Differentially methylated position analysis was performed using age, sex and cell proportions as covariates. Integration of paired genomic and transcriptomic layers was done with Multi-Omics Factor Analysis v2 (MOFA). Unsupervised principal component analyses were performed to examine correlates of treatment escalation and clinical predictors of disease severity.Results: We report 137 differentially methylated positions (DMP) in whole blood in IBD, including VMP1/MIR21 (p=9.11×10-15) and RPS6KA2 (6.43×10-13); with consistency seen across Scandinavia and UK. Cell of origin analysis preferentially implicated the monocyte lineage. Dysregulated loci demonstrate strong genetic influence, notably VMP1 (p=1.53×10-15). Age acceleration is seen in IBD (coefficient 0.94, p<2.2x10-16). Several immuno-active genes demonstrated highly significant correlations between methylation and gene expression in IBD, in particular OSM: IBD r -0.32, p 3.64×10-7 vs. non-IBD r -0.14, p=0.77). Multi-omic integration of methylome, genome and transcriptome also identified specific pathways that associate with immune activation, response and regulation at disease inception. At follow up, a signature of 3 DMPs (TAP1, TESPA1, RPTOR) associated with treatment escalation to biological agents or surgery (hazard ratio of 5.19 (CI:2.14-12.56, logrank p=9.70×10-4).Conclusion: This study highlights the stability of the IBD-specific circulating methylome across regions with shared ancestry. Through integrative multi-omic analyses we identify key pro-inflammatory genes that are upregulated in IBD at inception. Furthermore, differential methylation within certain genes such as TAP1 associate with disease course over time.
  •  
2.
  • Olbjern, Christine, et al. (författare)
  • Fecal microbiota profiles in treatment-naive pediatric inflammatory bowel disease : associations with disease phenotype, treatment, and outcome
  • 2019
  • Ingår i: Clinical and Experimental Gastroenterology. - Macclesfield, United Kingdom : DOVE MEDICAL PRESS LTD. - 1178-7023. ; 12, s. 37-49
  • Tidskriftsartikel (refereegranskat)abstract
    • Purpose: Imbalance in the microbiota, dysbiosis, has been identified in inflammatory bowel disease (IBD). We explored the fecal microbiota in pediatric patients with treatment-naive IBD, non-IBD patients with gastrointestinal symptoms and healthy children, its relation to IBD subgroups, and treatment outcomes. Patients and methods: Fecal samples were collected from 235 children below 18 years of age. Eighty children had Crohns disease (CD), 27 ulcerative colitis (UC), 3 IBD unclassified, 50 were non-IBD symptomatic patients, and 75 were healthy. The bacterial abundance of 54 predefined DNA markers was measured with a 16S rRNA DNA-based test using GA-Map (TM) technology at diagnosis and after therapy in IBD patients. Results: Bacterial abundance was similarly reduced in IBD and non-IBD patients in 51 of 54 markers compared to healthy patients (Pamp;lt;0.001). Only Prevotella was more abundant in patients (Pamp;lt;0.01). IBD patients with ileocolitis or total colitis had more Ruminococcus gnavus (P=0.02) than patients with colonic CD or left-sided UC. CD patients with upper gastrointestinal manifestations had higher Veillonella abundance (Pamp;lt;0.01). IBD patients (58%) who received biologic therapy had lower baseline Firmicutes and Mycoplasma hominis abundance (Pamp;lt;0.01) than conventionally treated. High Proteobacteria abundance was associated with stricturing/penetrating CD, surgery (Pamp;lt;0.01), and nonmucosal healing (Pamp;lt;0.03). Low Faecalibacterium prausnitzii abundance was associated with prior antibiotic therapy (P=0.001), surgery (P=0.02), and nonmucosal healing (Pamp;lt;0.03). After therapy, IBD patients had unchanged dysbiosis. Conclusion: Fecal microbiota profiles differentiated IBD and non-IBD symptomatic children from healthy children, but displayed similar dysbiosis in IBD and non-IBD symptomatic patients. Pretreatment fecal microbiota profiles may be of prognostic value and aid in treatment individualization in pediatric IBD as severe dysbiosis was associated with an extensive, complicated phenotype, biologic therapy, and nonmucosal healing. The dysbiosis persisted after therapy, regardless of treatments and mucosal healing.
  •  
3.
  • Ahlen, Gustaf, et al. (författare)
  • Limited effect on NS3-NS4A protein cleavage after alanine substitutions within the immunodominant HLA-A2-restricted epitope of the hepatitis C virus genotype 3a non-structural 3/4A protease.
  • 2012
  • Ingår i: The Journal of general virology. - : Microbiology Society. - 1465-2099 .- 0022-1317. ; 93:Pt 8, s. 1680-1686
  • Tidskriftsartikel (refereegranskat)abstract
    • It has been well established that immunological escape mutations within the hepatitis C virus genotype (gt) 1a non-structural (NS) 3/4A protease is partly prevented by a reduction of the viral protease fitness. Surprisingly little is known whether similar mutations affect proteases from other genotypes. In the present study, we assessed both the human leukocyte antigen (HLA)-A2-restricted cytotoxic T cell response and gt3a NS3/4A protease fitness. Similar to gt1, the 1073-1081 epitope was also immunodominant within the gt3a-specific HLA-A2-restricted cytotoxic T cell response, despite a homology of only 56% between gt1a and gt3a genes. However, unlike the gt1a NS3/4A protease, all residues within the gt3a 1073-1081 epitope could sequentially be replaced by alanine with a, at least in part, retained protease activity.
  •  
4.
  • Aleman, Soo, et al. (författare)
  • Frequent loss to follow-up after diagnosis of hepatitis C virus infection : A barrier towards the elimination of hepatitis C virus
  • 2020
  • Ingår i: Liver international (Print). - : Wiley-Blackwell Publishing Inc.. - 1478-3223 .- 1478-3231. ; 40:8, s. 1832-1840
  • Tidskriftsartikel (refereegranskat)abstract
    • BACKGROUND: Previous studies on hepatitis C cascade of care have been mainly focused on diagnosis and treatment rate, while less attention has been given to patients lost to follow-up (LTFU) after diagnosis. Analyses of this latter issue on population level are missing.AIMS: In this nationwide study of people with HCV, we aimed to estimate the proportion LTFU after HCV diagnosis, characterize them, and analyze their other healthcare contacts.METHODS: Patients diagnosed with chronic HCV in the Swedish National Patient register during 2001-2011 and still alive December 31, 2013, were included. The number of cured patients without need of follow-up was estimated. Visits to HCV specialist care during 2012-2013 were analysed. For those LTFU, other specialist care contacts were studied.RESULTS: In total 29,217 patients were included, with 24,733 with need of HCV care. 61% (n=15,007) of them were LTFU from HCV care in 2012-2013 and 58% did not attend HCV care during the second year after HCV diagnosis. The departments of surgery/orthopedic or psychiatry/dependency were the most common other non-primary healthcare contacts. Predictors for LTFU were young age, male sex, low education, presence of psychiatric/dependency diagnosis, unmarried, and longer duration since diagnosis of HCV.CONCLUSIONS: This study showed that almost two-thirds of patients were LTFU after HCV diagnosis, with frequent occurrence early after diagnosis. Efforts to link patients back to HCV care, in combination with early and easy access to HCV treatment and harm reduction, are necessary to reach the HCV elimination goal.
  •  
5.
  •  
6.
  • Alm, Klas Håkan, et al. (författare)
  • International Higher Education : Local Initiatives Enabling Global Citizens
  • 2016
  • Konferensbidrag (refereegranskat)abstract
    • Education at University of Borås is internationally connected to varying degree and form. This report looks at a selection of initiatives in order to explore the past, present and future role of UB internationalization. As a basis for the review, 7 students are interviewed on their international experience in their education – exchange studies and minor field studies (MFS) respectively. The participants stress the role of personal development and career enablement, and perceive their international experience as a distinct, unique element of their education. Possibilities and problems are then identified and related to the current literature on international education, learning and pedagogics. The study lands in a critical discussion on the future development of UB education. Key points of development: To meet the Bologna 20 percent commitment, more efforts need to be made on promoting and enabling internationalization to students, faculty and administrators. Curricular hurdles need to be removed as not to hamper students’ programme progression for going abroad. Teachers’ competency building efforts such as the Teaching and learning in higher education course could benefit from further elements of internationalization.
  •  
7.
  • Askarieh, Galia, 1983, et al. (författare)
  • Systemic and intrahepatic interferon-gamma-inducible protein 10 kDa predicts the first-phase decline in hepatitis C virus RNA and overall viral response to therapy in chronic hepatitis C.
  • 2010
  • Ingår i: Hepatology. - : Ovid Technologies (Wolters Kluwer Health). - 1527-3350 .- 0270-9139. ; 51:5, s. 1523-1530
  • Tidskriftsartikel (refereegranskat)abstract
    • High systemic levels of interferon-gamma-inducible protein 10 kDa (IP-10) at onset of combination therapy for chronic hepatitis C virus (HCV) infection predict poor outcome, but details regarding the impact of IP-10 on the reduction of HCV RNA during therapy remain unclear. In the present study, we correlated pretreatment levels of IP-10 in liver biopsies (n = 73) and plasma (n = 265) with HCV RNA throughout therapy within a phase III treatment trial (DITTO-HCV). Low levels of plasma or intrahepatic IP-10 were strongly associated with a pronounced reduction of HCV RNA during the first 24 hours of treatment in all patients (P < 0.0001 and P = 0.002, respectively) as well as when patients were grouped as genotype 1 or 4 (P = 0.0008 and P = 0.01) and 2 or 3 (P = 0.002, and P = 0.02). Low plasma levels of IP-10 also were predictive of the absolute reduction of HCV RNA (P < 0.0001) and the maximum reduction of HCV RNA in the first 4 days of treatment (P < 0.0001) as well as sustained virological response (genotype 1/4; P < 0.0001). To corroborate the relationship between early viral decline and IP-10, pretreatment plasma samples from an independent phase IV trial for HCV genotypes 2/3 (NORDynamIC trial; n = 382) were analyzed. The results confirmed an association between IP-10 and the immediate reduction of HCV RNA in response to therapy (P = 0.006). In contrast, pretreatment levels of IP-10 in liver or in plasma did not affect the decline of HCV RNA between days 8 and 29, i.e., the second-phase decline, or later time points in any of these cohorts. CONCLUSION: In patients with chronic hepatitis C, low levels of intrahepatic and systemic IP-10 predict a favorable first-phase decline of HCV RNA during therapy with pegylated interferon and ribavirin for genotypes of HCV.
  •  
8.
  • Bergemalm, Daniel, 1977-, et al. (författare)
  • Systemic Inflammation in Preclinical Ulcerative Colitis
  • 2021
  • Ingår i: Gastroenterology. - : AGA Institute. - 0016-5085 .- 1528-0012. ; 161:5, s. 1526-1539.e9
  • Tidskriftsartikel (refereegranskat)abstract
    • Background & Aims: Preclinical ulcerative colitis is poorly defined. We aimed to characterize the preclinical systemic inflammation in ulcerative colitis, using a comprehensive set of proteins.Methods: We obtained plasma samples biobanked from individuals who developed ulcerative colitis later in life (n = 72) and matched healthy controls (n = 140) within a population-based screening cohort. We measured 92 proteins related to inflammation using a proximity extension assay. The biologic relevance of these findings was validated in an inception cohort of patients with ulcerative colitis (n = 101) and healthy controls (n = 50). To examine the influence of genetic and environmental factors on these markers, a cohort of healthy twin siblings of patients with ulcerative colitis (n = 41) and matched healthy controls (n = 37) were explored.Results: Six proteins (MMP10, CXCL9, CCL11, SLAMF1, CXCL11 and MCP-1) were up-regulated (P < .05) in preclinical ulcerative colitis compared with controls based on both univariate and multivariable models. Ingenuity Pathway Analyses identified several potential key regulators, including interleukin-1β, tumor necrosis factor, interferon-gamma, oncostatin M, nuclear factor-κB, interleukin-6, and interleukin-4. For validation, we built a multivariable model to predict disease in the inception cohort. The model discriminated treatment-naïve patients with ulcerative colitis from controls with leave-one-out cross-validation (area under the curve = 0.92). Consistently, MMP10, CXCL9, CXCL11, and MCP-1, but not CCL11 and SLAMF1, were significantly up-regulated among the healthy twin siblings, even though their relative abundances seemed higher in incident ulcerative colitis.Conclusions: A set of inflammatory proteins are up-regulated several years before a diagnosis of ulcerative colitis. These proteins were highly predictive of an ulcerative colitis diagnosis, and some seemed to be up-regulated already at exposure to genetic and environmental risk factors.
  •  
9.
  • Björk, Gunnar, et al. (författare)
  • Quantum degrees of polarization
  • 2010
  • Ingår i: Optics Communications. - : Elsevier BV. - 0030-4018 .- 1873-0310. ; 283:22, s. 4440-4447
  • Tidskriftsartikel (refereegranskat)abstract
    • We discuss different proposals for the degree of polarization of quantum fields. The simplest approach, namely making a direct analogy with the classical description via the Stokes operators, is known to produce unsatisfactory results. Still, we argue that these operators and their properties should be basic for any measure of polarization. We compare alternative quantum degrees and put forth that they order various states differently. This is to be expected, since, despite being rooted in the Stokes operators, each of these measures only captures certain characteristics. Therefore, it is likely that several quantum degrees of polarization will coexist, each one having its specific domain of usefulness.
  •  
10.
  • Björk, Gunnar, et al. (författare)
  • Two-photon imaging and quantum holography
  • 2004
  • Ingår i: Journal of Optics B-Quantum and Semiclassical Optics. - : IOP Publishing. - 1464-4266 .- 1741-3575. ; 6:6, s. S478-S482
  • Tidskriftsartikel (refereegranskat)abstract
    • We discuss when the use of entangled photon pairs in an imaging system can be simulated with a classically correlated source. In particular, we consider two recently proposed schemes with 'bucket detection' of one of the photons. We argue that these schemes give identical results for entangled states as for appropriately prepared classically correlated states.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 64
Typ av publikation
tidskriftsartikel (49)
annan publikation (5)
rapport (4)
doktorsavhandling (4)
konferensbidrag (2)
Typ av innehåll
refereegranskat (42)
övrigt vetenskapligt/konstnärligt (18)
populärvet., debatt m.m. (4)
Författare/redaktör
Halfvarson, Jonas, 1 ... (22)
Söderholm, Jonas, 19 ... (17)
Repsilber, Dirk, 197 ... (14)
Bergemalm, Daniel, 1 ... (13)
Söderholm, Jonas (10)
Söderholm, Johan D (10)
visa fler...
Kruse, Robert, 1972- (10)
Ricanek, P (7)
D'Amato, Mauro (7)
D'Amato, M (6)
Satsangi, J (6)
Hellstrand, Kristoff ... (6)
Carlson, M (6)
Lindqvist, Carl Mårt ... (6)
Kalla, R (5)
Vatn, S (5)
Gomollon, F (5)
Jahnsen, J (5)
Hjortswang, Henrik (5)
Satsangi, Jack (5)
Björk, Gunnar (4)
Söderholm, Johan D., ... (4)
Lagging, Martin, 196 ... (4)
Eriksson, Carl, 1981 ... (4)
Aleman, Soo (4)
Westin, Johan, 1965 (4)
Gomollon, Fernando (3)
Frelin, Lars (3)
Carlson, Marie (3)
Magnusson, Maria K, ... (3)
Öhman, Lena, 1967 (3)
Salihovic, Samira, A ... (3)
Lampinen, Maria (3)
Grafström, Jonas, 19 ... (3)
Venge, Per (3)
Büsch, Katharina (3)
Kövamees, Jan (3)
Duberg, Ann-Sofi, Do ... (3)
Norkrans, Gunnar, 19 ... (3)
Lindh, Magnus, 1960 (3)
Öhman, Lena (3)
Askarieh, Galia, 198 ... (3)
Carlson, Marie, 1957 ... (3)
Bazov, Igor, 1973- (3)
Strid, H (3)
Keita, Åsa (3)
Kalla, Rahul (3)
Söderholm, Johan (3)
Olbjørn, Christine (3)
Söderholm, J. (3)
visa färre...
Lärosäte
Örebro universitet (25)
Karolinska Institutet (19)
Göteborgs universitet (16)
Linköpings universitet (15)
Högskolan i Borås (8)
Uppsala universitet (6)
visa fler...
Kungliga Tekniska Högskolan (5)
Luleå tekniska universitet (5)
Lunds universitet (4)
Umeå universitet (3)
Jönköping University (2)
Chalmers tekniska högskola (2)
VTI - Statens väg- och transportforskningsinstitut (1)
visa färre...
Språk
Engelska (61)
Svenska (3)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (42)
Samhällsvetenskap (13)
Naturvetenskap (4)
Teknik (3)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy